A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer

NCT04380012 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Pyrotinib
DRUG: Pyrotinib in combination with trastuzumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]